Point of View: Open science takes on Parkinson’s disease
Figures
![](https://iiif.elifesciences.org/lax/66546%2Felife-66546-fig1-v1.tif/full/617,/0/default.jpg)
Overview of the ASAP Initiative.
ASAP currently supports the Collaborative Research Network and four resource programs: the Global Parkinson’s Genetics Program (GP2); the Parkinson’s Progression Markers Initiative (PPMI); the Accelerating Medicines Partnership for Parkinson’s disease (AMP-PD) program; and the iPSC Neurodegenerative Diseases Initiative (iNDI), which is not covered in this article. Open science and open access are core tenets of ASAP's supported programs.
![](https://iiif.elifesciences.org/lax/66546%2Felife-66546-fig2-v1.tif/full/617,/0/default.jpg)
Team structure in the ASAP Collaborative Research Network.
The Core Leadership of each team consists of 3–5 PIs, at least one of whom must be an early-career investigator; each team also has a Coordinator Lead PI who is responsible for overall project management and for reporting to ASAP/MJFF staff. To ensure multi-disciplinarity and geographical diversity, at least two different disciplines and between two and five institutions must also be represented across the Core Leadership.